Burkhard Greve

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Sherif Ibrahim, Ramy Gadalla, Eslam A. Elghonaimy et al. · Molecular Cancer · 2017 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +17

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling

Sherif Ibrahim, Hebatallah Hassan, Laura Vilardo et al. · PLoS ONE · 2013 · 117 citations · Full text

Medicine, Cell Biology, Oncology +17

Simple and fast spectral domain algorithm for quantitative phase imaging of living cells with digital holographic microscopy

Junwei Min, Baoli Yfao, Steffi Ketelhut et al. · Optics Letters · 2017 · 108 citations · Full text

Natural Sciences, Biophysics, Cell Biology +15

Organization of Seminiferous Epithelium in Primates: Relationship to Spermatogenic Efficiency, Phylogeny, and Mating System1

Joachim Wistuba, Annette Schrod, Burkhard Greve et al. · Biology of Reproduction · 2003 · 107 citations · Full text

Life Sciences, Biology, Zoology +10

Syndecan‐1 modulates β‐integrin‐dependent and interleukin‐6‐dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation

Hebatallah Hassan, Burkhard Greve, Mauro S.G. Pavão et al. · FEBS Journal · 2013 · 104 citations

Life Sciences, Cancer Biology, Oncology +17